Non-alcoholic fatty liver disease: Diagnosing, managing and cardiovascular risks

On-demand recorded 16 Jul 2020

The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be approximately 30% of adults in Australia. NAFLD is associated with increased liver-related morbidity and mortality, and increased cardiovascular disease and cancer risk. The session covers: - the challenges of confidently diagnosing NAFLD and the tools available to assist - evidence-based approaches to managing NAFLD - cardiovascular risks associated with NAFLD and the specific management.

Learning outcomes

• Discuss the challenges of confidently diagnosing non-alcoholic fatty liver disease and the tools available to assist this process
• Outline evidence-based approaches to managing non-alcoholic fatty liver disease
• Discuss the cardiovascular risks associated with non-alcoholic fatty liver disease and the specific management

This event attracts 3 CPD points

Speakers

Dr Tom Zhou
Hepatologist and Gastroenterologist

Dr Paul McEniery
Interventional Cardiologist

Dr Claire Poolman
General Practitioner